Unleash Business Potential with Xentria Inc Your Innovation Partner

Xentria, Inc. 0 followers. ‌. Xentria is a venture studio that provides capital and insight into breakthrough science that aligns with our core therapeutic ... Xentria will license its experimental pulmonary sarcoidosis drug to Meitheal Pharmaceuticals in a deal worth up to $680 million. ... LTD 持股36.00% 公司实际控制人、董事谢菊华控制的Scitakos 持有Xentria 36%的股权。 Xentria, Inc（以下简称“Xentria”）目前不属于上市公司，公司未 ... Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development ... Xentria, Inc., a Chicago-based clinical-stage... Home ... With this funding, the company advance the Xentria pipeline and execute against the goal of developing critical therapeutics for patients in ... Related Company Profiles. Xentria Inc · Meitheal Pharmaceuticals Inc · View all. Meitheal will obtain sole rights to market the biologic in ... Trademark registration by Xentria, Inc. for the trademark XENTRIA. company logo. XENTRIA INC. 2 of 2 Job Opportunities. All Departments. All Locations. Job, Post Date , Department. Xentria Investigative Site. Bloemfontein, South Africa, 9301. Central trial contact. Xentria Inc. Xentria Inc. Contact trial. Similar trials. A ... The Xentria trial is a Phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis. See below for information about the trial sites for this clinical ...